Filter
806
Filtered Results: 806
Text search:
Pharmaceutical
procurement
and
distribution
Featured
Recommendations
81
New Publications
274
Language
Document type
No document type
448
Studies & Reports
143
Guidelines
106
Strategic & Response Plan
49
Manuals
37
Situation Updates
8
Fact sheets
8
Training Material
6
Resource Platforms
1
Countries / Regions
Ethiopia
48
Kenya
43
India
29
Uganda
28
Global
27
Sierra Leone
23
Liberia
22
Nigeria
22
South Africa
19
Malawi
18
Ghana
17
Nepal
16
Tanzania
15
Zambia
13
Rwanda
13
Namibia
13
Ukraine
12
Zimbabwe
11
Lesotho
11
Western and Central Europe
11
Philippines
10
Bangladesh
10
Cambodia
8
Eastern Europe
8
Senegal
6
Congo, Democratic Republic of
6
Syria
6
Indonesia
6
Botswana
6
Myanmar / Burma
6
Africa
6
Burkina Faso
5
Benin
5
Latin America and the Carribbean
5
Asia
5
Cameroon
4
Haiti
4
Eswatini/ Swaziland
4
Mozambique
3
Papua New Guinea
3
Sudan
3
West and Central Africa
3
South–East Asia Region
3
Guinea
2
Pakistan
2
South Sudan
2
Thailand
2
East and Southern Africa
2
Western Pacific Region
2
Albania
2
North America
2
Mali
1
Somalia
1
Jordan
1
Lebanon
1
Central African Republic
1
Brazil
1
Libya
1
Yemen
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Moldova
1
Gabon
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
429
Clinical Guidelines
42
Public Health
27
Key Resources
26
Pharmacy & Technologies
19
Women & Child Health
17
Capacity Building
2
Annual Report MEDBOX
1
Toolboxes
Pharmacy
82
AMR
72
COVID-19
55
HIV
47
TB
41
Rapid Response
19
Health Financing Toolbox
17
Conflict
16
Planetary Health
13
Global Health Education
12
NTDs
12
NCDs
9
Ebola
8
Mental Health
6
Polio
3
Natural Hazards
3
Caregiver
3
Disability
2
Cholera
2
Refugee
2
Health Financing
2
Zika
1
Specific Hazards
1
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying ... managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisectoral population-based interventions to reduce CVD risk factors in the entire population.
Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs.
Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of
individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management.
Conclusion: The large burden of CVD in LMICs and the fact that persons with high
CVD can be identified and managed along cost-effective interventions mean that
health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level.
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and man...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medici...
The TB section of the toolkit presents selected (a) programmatic output and (b) outcome and impact indicators for TB. In addition to recommended monitoring programs ... measuring the outcomes and impact of TB programs, indicators for the strengthening of health systems, strengthening of community systems and some indicators that measure quality of services are also included.
Meeting Report
27–30 June 2017 Manila, Philippines
This report assesses the impact of the conflict in Ukraine and its implications for organized crime and security-related issues for neighbouring countries, with a focus on Moldova.
These include:...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa...
This curricula guide builds on several existing products of WHO and partners, aimed at supporting countries in their effort to address the first objective of the GAP-AMR (to improve awareness and un...
India contributes to 16% of the global maternal deaths and around 27% of global newborn deaths. Reducing the burden of maternal and newborn mortality and<...
